Skip to main content
. 2012 Mar 21;18(11):1216–1228. doi: 10.3748/wjg.v18.i11.1216

Table 2.

Results of mass spectrometry identification

Protein name Gene name Swiss-Prot ID pI/MW Frequency1 Fold2 P value Coverage3 No. of pep.4
Down-regulated
Gastrokine-1 precursor GKN1 Q9NS71 5.3/21.0 75% (9/12) 15.17 0.000 16% 6
15-hidroxyprostaglandin dehydrogenase isoform 1 HPGD P15428 5.6/25.2 66% (8/12) 3.85 0.016 23% 5
Enoyl CoA hydratase, mitochondrial precursor ECHS1 P30084 5.8/27.9 66% (8/12) 3.38 0.001 49% 15
39S ribosomal protein L12, mitochondrial precursor MRPL12 P52815 5.1/20.6 58.3% (7/12) 10.95 0.016 16% 4
Acyl-CoA dehydrogenase ACADS P16219 6.1/39.9 58.3% (7/12) 4.94 0.005 12% 5
NADH dehydrogenase (ubiquinone) flavoprotein 2, mitochondrial precursor NDUFV2 P19404 5.7/24.2 50% (6/12) 2.26 0.027 58% 16
Phenazine biosynthesis-like domain-containing protein isoform a PBLD P30039 6.1/31.8 50% (6/12) 3.60 0.007 25% 5
Plasma cell-induced resident endoplasmic reticulum protein PACAP Q8WU39 5.2/22.0 41.6% (5/12) 4.41 0.042 39% 5
ATP synthase subunit d, mitochondrial ATP5H O75947 5.2/20.5 41.6% (5/12) 2.40 0.012 26% 5
Glutathione S-transferase mu 3 GSTM3 P21266 5.3/26.3 33.3% (4/12) 3.35 0.042 29% 4
Transthyretin TTR P02766 5.4/16.4 25% (3/12) 2.74 0.027 53% 7
Up-regulated
Septin-2 SEPT2 Q15019 6.0/41.0 75% (9/12) 4.58 0.009 34% 7
Maspin SERPINB5 P36952 5.6/40.2 58.3% (7/12) 4.99 0.007 14% 5
Phosphoglycerate kinase 1 PGK1 P00558 6.0/40.1 58.3% (7/12) 6.46 0.016 22% 6
Pyruvate kinase, muscle PKM2 P14619 6.0/38.8 58.3% (7/12) 5.25 0.021 20% 8
Actin, cytoplasmic 1 ACTB P60709 4.8/32.2 58.3% (7/12) 7.77 0.005 44% 12
Tumor necrosis factor receptor superfamily member 16 precursor NGFR P08138 5.2/35.5 50% (6/12) 3.94 0.002 17% 5
Heat shock 70 kDa protein 1A/1B HSPA1 P08107 5.1/36.9 50% (6/12) 4.77 0.009 14% 8
Heterochromatin-like protein 1 CBX3 Q13185 5.2/22.0 50% (6/12) 4.12 0.027 19% 3
Ubiquitin-conjugating enzyme E2 N UBE2N P61088 5.7/16.4 41.6% (5/12) 4.94 0.001 40% 5
Transaldolase TALDO1 P37837 5.9/38.5 41.6% (5/12) 3.12 0.003 18% 5
Cathepsin D precursor CTSD P07339 5.3/28.4 41.6% (5/12) 3.49 0.034 27% 11
Annexin A4 ANXA4 P09525 5.6/31.3 41.6% (5/12) 13.31 0.027 54% 26
Myotrophin MTPN P58546 5.1/13.5 41.6% (5/12) 2.45 0.000 22% 4
Enolase 1 variant ENO1 P06733 5.5/42.6 41.6% (5/12) 3.95 0.034 19% 7
Nicotinamide N-methyltransferase NNMT P40261 5.4/28.5 41.6% (5/12) 4.24 0.000 9% 3
Eukaryotic translation initiation factor 2 subunit 1 EIF2S1 P05198 4.9/33.5 41.6% (5/12) 6.61 0.042 24% 8
Translationally-controlled tumor protein TPT1 P13693 4.8/20.7 25% (3/12) 2.50 0.002 18% 4
Annexin A5 ANXA5 P08758 5.0/32.4 25% (3/12) 3.24 0.005 70% 25
Nucleoside diphosphate kinase A isoform a NME1 P15531 5.7/19.0 25% (3/12) 3.11 0.016 33% 5
1

Frequency shows the number of patients where the protein was differentially expressed in two-dimensional gel electrophoresis analysis;

2

Fold stands for the average fold change in the relative spot volume between non-tumor and tumor (downregulated) or tumor and non-tumor (upregulated) tissue;

3

Coverage stands for the sequence coverage in mass spectrometry (MS) analysis;

4

No. of pep. stands for the number of matched peptides in MS analysis. MW: Molecular weight.